Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Human Pathology|June 19, 2026
Evaluation of Prognostic Factors and Outcomes in Primary versus Secondary Myeloid SarcomaChristine W Kahlow, Sharon Germans, Maximiliano Ramia de Cap, et al.
Haematologica|December 24, 2025
Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s)Sa A Wang, Chi Young Ok, Harrison K Tsai, et al.
Blood|November 8, 2019
Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversionYan Xiu, Qianze Dong, Lin Fu, et al.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Blood|March 15, 2014
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasmsSa A Wang, Robert P Hasserjian, Patricia S Fox, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Blood Advances|February 14, 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registrySheila K Pierson, Joshua D Brandstadter, Drew A Torigian, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Cell|June 2, 2018
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid LeukemiaMiriam Y Kim, Kyung-Rok Yu, Saad S Kenderian, et al.
Leukemia & Lymphoma|March 24, 2023
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology GroupMaximiliano Ramia de Cap, Leo P Wu, Christian Hirt, et al.
Pageof 18